Omega-3 Drug Firm’s Trade Complaint Questions US Dietary Ingredient Standards

Amarin targets purified EPA dietary supplements or formulations containing primarily EPA in ethyl ester or re-esterified form and raises general questions about using synthetic dietary ingredients in supplements and about the extent to which a substance’s previous identification as an IND candidate precludes its subsequent use as a dietary ingredient.

A pharmaceutical firm’s fair trade complaint targeting purified eicosapentaenoic acid dietary supplements or omega-3 formulations containing primarily EPA in ethyl ester or re-esterified form questions FDA criteria for allowing the use of certain ingredients in supplement products.

Amarin Corp. PLC’s complaint filed on Aug. 30 with the US International Trade Commission more narrowly could affect the...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Legal

More from Policy & Regulation